Pelthos Therapeutics

Pelthos Therapeutics is a biopharmaceutical company committed to commercializing innovative therapeutic products for high unmet patient needs. The company’s lead product is ZELSUVMI™ (berdazimer) topical gel, 10.3%, for the treatment of Molluscum contagiosum.